Fetomaternal outcome in patients with placenta previa.
Morbidly adherent placenta
Placenta previa
Postpartum hemorrhage caesarean hysterectomy
Journal
Pakistan journal of medical sciences
ISSN: 1682-024X
Titre abrégé: Pak J Med Sci
Pays: Pakistan
ID NLM: 100913117
Informations de publication
Date de publication:
Historique:
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
25
7
2020
Statut:
ppublish
Résumé
To assess maternal and fetal morbidity associated with placenta previa and morbidly adherent placenta (MAP). All patients with placenta previa who delivered in services hospital from April 1, 2017 to March 31, 2019 were included. Maternal and fetal outcomes were compared amongst patients with placenta previa and MAP. Total of 8002 patients delivered with 152 (1.9%) diagnosed as placenta previa and 56 (36.8%) amongst them had MAP. One hundred thirty-one out of One hundred fifty-two (86.1%) of our patients were booked. Increased number of caesarean section, multi parity and anterior placenta had significant association with MAP (p<0.0001). Maternal morbidity in terms of postpartum hemorrhage >2000ml, caesarean hysterectomy, number of blood transfusions, bladder injury, need for ICU admission was significantly more in patients with MAP (p<0.0001). Case fatality was 3% with two maternal deaths in MAP and none in placenta previa. Fetal outcome was good in both groups as gestational age at delivery was 36 weeks or more, birth weight was ≥ 2.5 kg and >6 APGAR score (p<0.05). Two neonatal deaths occurred in MAP and one in placenta previa owing to prematurity. MAP is a dreadful complication of placenta previa with increased maternal morbidity. Regular antenatal care with adequate arrangement of blood transfusion and multidisciplinary approach can reduce maternal mortality.
Identifiants
pubmed: 32704270
doi: 10.12669/pjms.36.5.1647
pii: PJMS-36-952
pmc: PMC7372655
doi:
Types de publication
Journal Article
Langues
eng
Pagination
952-957Informations de copyright
Copyright: © Pakistan Journal of Medical Sciences.
Déclaration de conflit d'intérêts
Conflict of interest: None.
Références
BMJ Open. 2017 Oct 5;7(10):e017713
pubmed: 28982832
Acta Obstet Gynecol Scand. 2018 Jan;97(1):25-37
pubmed: 28963728
J Matern Fetal Neonatal Med. 2014 Jan;27(1):24-9
pubmed: 23638753
Trop Med Int Health. 2013 Jun;18(6):712-24
pubmed: 23551357
J Ayub Med Coll Abbottabad. 2011 Apr-Jun;23(2):93-6
pubmed: 24800353
Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Sep;48(5):783-787
pubmed: 29130675
Trop Doct. 2015 Jul;45(3):183-7
pubmed: 25979844
Obstet Gynecol. 2010 Mar;115(3):637-44
pubmed: 20177297
J Matern Fetal Neonatal Med. 2011 Nov;24(11):1341-6
pubmed: 21381881
J Obstet Gynaecol India. 2017 Feb;67(1):42-47
pubmed: 28242967
PLoS One. 2018 Jul 17;13(7):e0200252
pubmed: 30016336
Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402
pubmed: 26002174
J Matern Fetal Neonatal Med. 2014 Nov;27(17):1734-7
pubmed: 24397837
J Perinat Med. 2013 Mar;41(2):141-9
pubmed: 23241664
J Perinatol. 2016 Dec;36(12):1073-1078
pubmed: 27583391
Hong Kong Med J. 2015 Dec;21(6):511-7
pubmed: 26554269
J Pregnancy. 2017;2017:5936309
pubmed: 28321338
BJOG. 2019 Jan;126(1):e1-e48
pubmed: 30260097
PLoS One. 2017 Jan 20;12(1):e0170194
pubmed: 28107460